• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

资源短缺影响的感染控制干预措施:对碳青霉烯类耐药病原体引起的菌血症发病率的影响。

Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.

机构信息

Infection Control Committee, Tzaneio General Hospital, Piraeus, Greece.

Department of Clinical Microbiology, Tzaneio General Hospital, Piraeus, Greece.

出版信息

Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):43-50. doi: 10.1007/s10096-017-3098-1. Epub 2017 Sep 6.

DOI:10.1007/s10096-017-3098-1
PMID:28879405
Abstract

We evaluated an infection control (IC) program influenced by personnel and material resource shortages on the incidence of bloodstream infections (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPA) in an endemic region. Between January 2010 and December 2015, all BSI episodes caused by CRKP, CRAB, and CRPA were recorded. An IC bundle was implemented in January 2012. We evaluated the effect of the interventions on BSI rates between the pre-intervention (2010-2011) and intervention (2012-2013) periods, using an interrupted time-series model. From 2014, when interventions were still applied, BSI incidence was gradually increased. For this reason, we evaluated with a linear mixed effects model several factors possibly contributing to this increase for the years 2012-2015, which was considered as the intervention/follow-up period. During the study period, 351 patients with BSI were recorded, with a total of 538 episodes; the majority (83.6%) occurred in the intensive care unit (ICU). The BSI incidence rate per year during 2010-2015 for ICU patients was 21.03/19.63/17.32/14.45/22.85/25.02 per 1000 patient-days, respectively, with the reduction in BSI levels after the start of intervention marginal (p = 0.054). During the follow-up period (2014-2015), the most influential factors for the increased BSI incidence were the reduced participation in educational courses and compliance with hand hygiene. The implementation of IC interventions reduced the BSI incidence rates, particularly for ICU patients. However, factors possibly related to the restrictions of human and material resources apparently contributed to the observed expansion of BSI in our endemic setting.

摘要

我们评估了在人员和物质资源短缺的情况下,感染控制(IC)计划对流行地区耐碳青霉烯类肺炎克雷伯菌(CRKP)、鲍曼不动杆菌(CRAB)和铜绿假单胞菌(CRPA)引起血流感染(BSI)发生率的影响。在 2010 年 1 月至 2015 年 12 月期间,记录了所有由 CRKP、CRAB 和 CRPA 引起的 BSI 病例。2012 年 1 月实施了感染控制措施。我们使用中断时间序列模型评估了干预措施对干预前(2010-2011 年)和干预期间(2012-2013 年)BSI 发生率的影响。2014 年,当干预措施仍在实施时,BSI 的发病率逐渐增加。因此,我们使用线性混合效应模型评估了 2012-2015 年可能导致发病率增加的几个因素,这一年被认为是干预/随访期。在研究期间,记录了 351 例 BSI 患者,共 538 例;大多数(83.6%)发生在重症监护病房(ICU)。2010-2015 年 ICU 患者每年 BSI 发生率分别为 21.03/19.63/17.32/14.45/22.85/25.02/1000 患者日,干预开始后 BSI 水平略有下降(p=0.054)。在随访期间(2014-2015 年),导致 BSI 发病率增加的最主要因素是参加教育课程和遵守手卫生的人数减少。感染控制干预措施的实施降低了 BSI 发生率,尤其是 ICU 患者。然而,与人员和物质资源限制有关的因素显然导致了我们流行地区 BSI 的扩张。

相似文献

1
Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.资源短缺影响的感染控制干预措施:对碳青霉烯类耐药病原体引起的菌血症发病率的影响。
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):43-50. doi: 10.1007/s10096-017-3098-1. Epub 2017 Sep 6.
2
Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.密集医疗单位中地方性抗碳青霉烯革兰氏阴性菌的分子流行病学。
Microb Drug Resist. 2019 Jun;25(5):712-716. doi: 10.1089/mdr.2018.0266. Epub 2018 Dec 27.
3
Bacterial bloodstream infections in level-I trauma intensive care unit in Serbia: incidence, causative agents and outcomes.塞尔维亚一级创伤重症监护病房的细菌血流感染:发病率、病原体及转归
J Infect Dev Ctries. 2018 Dec 31;12(12):1079-1087. doi: 10.3855/jidc.10737.
4
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.希腊重症监护病房耐碳青霉烯类 versus 碳青霉烯类敏感鲍曼不动杆菌菌血症:危险因素、临床特征和结局。
Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.
5
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant : a 4-year quasi-experimental before-and-after study.感染预防和控制干预措施以减少 ICU 获得性耐碳青霉烯类肠杆菌科细菌定植和感染:一项为期 4 年的准实验前后研究。
Antimicrob Resist Infect Control. 2019 Jan 10;8:8. doi: 10.1186/s13756-018-0453-7. eCollection 2019.
6
Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective.韩国某大学医院对耐碳青霉烯鲍曼不动杆菌的成功控制:六年视角
Am J Infect Control. 2014 Sep;42(9):976-9. doi: 10.1016/j.ajic.2014.05.027.
7
Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.爱沙尼亚重症监护病房中鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌的流行情况及抗生素敏感性:与欧洲数据的比较
Scand J Infect Dis. 2006;38(11-12):1001-8. doi: 10.1080/00365540600786507.
8
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in complex bacteraemia: experience from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) Network.复杂血流感染碳青霉烯耐药的危险因素、临床特征和结局的前瞻性多中心评估:来自中国医院感染抗菌药物耐药监测网(CARES)的经验。
J Med Microbiol. 2020 Jul;69(7):949-959. doi: 10.1099/jmm.0.001222.
9
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).ESKAPE 和大肠埃希菌引起的血流感染的发生率和抗菌药物耐药趋势:罗马一家大型教学医院的 9 年分析(2007-2015 年)。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1627-1636. doi: 10.1007/s10096-018-3292-9. Epub 2018 Jun 9.
10
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.同一流行都市地区医院内耐碳青霉烯类肺炎克雷伯菌血流感染的流行病学、管理和结局。
J Infect Public Health. 2018 Mar-Apr;11(2):171-177. doi: 10.1016/j.jiph.2017.06.003. Epub 2017 Jun 28.

引用本文的文献

1
Efficacy of Active Rapid Molecular Screening and IPC Interventions on Carbapenem-Resistant Infections in Emergency Intensive Care Units without Enough Single-Room Isolation.主动快速分子筛查及感染预防与控制干预措施对单间隔离不足的急诊重症监护病房耐碳青霉烯类感染的疗效
Infect Drug Resist. 2023 Feb 20;16:1039-1048. doi: 10.2147/IDR.S396331. eCollection 2023.
2
Carbapenem-resistant : A challenge in the intensive care unit.耐碳青霉烯类:重症监护病房中的一项挑战。
Front Microbiol. 2022 Nov 10;13:1045206. doi: 10.3389/fmicb.2022.1045206. eCollection 2022.
3
Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay.

本文引用的文献

1
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.产碳青霉烯酶肺炎克雷伯菌和大肠埃希菌在欧洲产碳青霉烯酶肠杆菌科的调查(EuSCAPE)中的发生:一项前瞻性、多国研究。
Lancet Infect Dis. 2017 Feb;17(2):153-163. doi: 10.1016/S1473-3099(16)30257-2. Epub 2016 Nov 18.
2
The Effect of a Nationwide Infection Control Program Expansion on Hospital-Onset Gram-Negative Rod Bacteremia in 130 Veterans Health Administration Medical Centers: An Interrupted Time-Series Analysis.全国感染控制计划扩大对 130 家退伍军人健康管理局医疗中心住院革兰氏阴性杆菌菌血症的影响:一项中断时间序列分析。
Clin Infect Dis. 2016 Sep 1;63(5):642-650. doi: 10.1093/cid/ciw423. Epub 2016 Jun 28.
3
耐碳青霉烯类革兰氏阴性病原体引起的血流感染对重症监护病房成本、死亡率和住院时间的影响。
Infect Prev Pract. 2019 Aug 23;1(2):100020. doi: 10.1016/j.infpip.2019.100020. eCollection 2019 Jun.
4
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.里约热内卢成人危重症患者耐碳青霉烯类革兰氏阴性杆菌所致脓毒症的预测因素:一项前瞻性队列研究中的病例对照设计。
Antimicrob Resist Infect Control. 2020 Aug 14;9(1):132. doi: 10.1186/s13756-020-00791-w.
5
Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.在流行地区含有产碳青霉烯酶肺炎克雷伯菌。
Antimicrob Resist Infect Control. 2020 Jul 6;9(1):102. doi: 10.1186/s13756-020-00766-x.
6
Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.在地方流行环境中耐万古霉素肠球菌和耐碳青霉烯革兰氏阴性菌的胃肠道携带情况:患病率、危险因素及转归
Front Public Health. 2020 Mar 18;8:55. doi: 10.3389/fpubh.2020.00055. eCollection 2020.
7
Reducing dissemination of carbapenem-resistant .减少耐碳青霉烯类药物的传播。
Ann Transl Med. 2019 Dec;7(Suppl 8):S365. doi: 10.21037/atm.2019.09.11.
8
Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.2014 至 2017 年意大利全国监测的产碳青霉烯酶肠杆菌科导致的血流感染。
Euro Surveill. 2019 Jan;24(5). doi: 10.2807/1560-7917.ES.2019.24.5.1800159.
9
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant : a 4-year quasi-experimental before-and-after study.感染预防和控制干预措施以减少 ICU 获得性耐碳青霉烯类肠杆菌科细菌定植和感染:一项为期 4 年的准实验前后研究。
Antimicrob Resist Infect Control. 2019 Jan 10;8:8. doi: 10.1186/s13756-018-0453-7. eCollection 2019.
Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.由对多重耐药菌进行主动筛查和针对性控制措施组成的两级感染控制管理策略的成本及可能的益处。
J Hosp Infect. 2016 Jun;93(2):191-6. doi: 10.1016/j.jhin.2016.02.013. Epub 2016 Mar 3.
4
Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes.三级医院重症监护病房获得性感染:一项流行病学调查及其对患者预后的影响。
Am J Infect Control. 2016 Jul 1;44(7):e113-7. doi: 10.1016/j.ajic.2016.01.021. Epub 2016 Mar 2.
5
Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.医院环境中的多重耐药革兰氏阴性菌感染:概述、对临床实践的影响及新出现的治疗选择
Microb Drug Resist. 2016 Jul;22(5):412-31. doi: 10.1089/mdr.2015.0220. Epub 2016 Feb 11.
6
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.欧洲产碳青霉烯酶肠杆菌科细菌:38 个国家的国家专家评估,2015 年 5 月。
Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30062.
7
Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party.多重耐药革兰氏阴性菌的预防与控制:联合工作组的建议
J Hosp Infect. 2016 Jan;92 Suppl 1:S1-44. doi: 10.1016/j.jhin.2015.08.007. Epub 2015 Nov 16.
8
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?消除多重耐药菌爆发的措施:需要花费多少?
Clin Microbiol Infect. 2016 Feb;22(2):162.e1-162.e9. doi: 10.1016/j.cmi.2015.10.001. Epub 2015 Oct 23.
9
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries.欧盟国家控制多重耐药革兰氏阴性菌指南中的争议。
Clin Microbiol Infect. 2015 Dec;21(12):1057-66. doi: 10.1016/j.cmi.2015.09.021. Epub 2015 Oct 3.
10
Minimum requirements in infection control.感染控制的最低要求。
Clin Microbiol Infect. 2015 Dec;21(12):1072-6. doi: 10.1016/j.cmi.2015.08.025. Epub 2015 Sep 10.